Assessment of clinical pharmacy interventions in the intensive care unit

Canadian Journal of Hospital Pharmacy

Volumn 66, Issue 4, 2013, Pages 212-218

  Ho, Claudia K ^a   Mabasa, Vincent H ^b   Leung, Vivian W Y ^c   Malyuk, Douglas L ^d   Perrott, Jerrold L ^d  

^a Lower Mainland Pharmacy Services   (Canada)

^b Burnaby Hospital   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d ROYAL COLUMBIAN HOSPITAL   (Canada)

Author keywords

Clinical pharmacy; Documentation; Interventions; Length of stay; Mortality; Patient outcomes

Indexed keywords

ADULT; ARTICLE; CLINICAL PHARMACY; COHORT ANALYSIS; FEMALE; HOSPITAL PATIENT; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; OUTCOME ASSESSMENT; PHARMACIST;

EID: 84908090263     PISSN: 00084123     EISSN: 19202903     Source Type: Journal    
DOI: 10.4212/cjhp.v66i4.1267     Document Type: Article

References (13)

1. Miller RR. History of clinical pharmacy and clinical pharmacology. J Clin Pharmacol. 1981;21(4):195-7.
2. Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;282(3):267-70.
3. Kopp BJ, Mrsan M, Erstad BL, Duby JJ. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist. Am J Health Syst Pharm. 2007;64(23):2483-7.
4. Health Professions Act-bylaws. Schedule F, Part 2. Hospital pharmacy standards of practice. Vancouver (BC): College of Pharmacists of British Columbia; 2010 [cited 2012 Apr 27]. Available from: http://library. bcpharmacists.org/D-Legislation-Standards/D-2-Provincial-Legislation/5079-HPA-Bylaws-Hospital.pdf
5. Gordon W, Malyuk D, Taki J. Use of health-record abstracting to document pharmaceutical care activities. Can J Hosp Pharm. 2000;53(3):199-205.
6. Bond CA, Raehl CL, Pitterle ME, Franke T. Health care professional staffing, hospital characteristics, and hospital mortality rates. Pharmacotherapy. 1999;19(2):130-8.
7. Wunsch H, Linde-Zwirble WT, Angus DC. Methods to adjust for bias and confounding in critical care health services research involving observational data. J Crit Care. 2006;21(1):1-7.
8. Bjornson DC, Hiner WO Jr, Potyk RP, Nelson BA, Lombardo FA, Morton TA, et al. Effect of pharmacists on health care outcomes in hospitalized patients. Am J Hosp Pharm. 1993;50(9):1875-84.
9. Boyko WL, Yurkowski PJ, Ivey MF, Armitstead JA, Roberts BL. Pharmacist influence on economic and morbidity outcomes in a tertiary care teaching hospital. Am J Health Syst Pharm. 1997;54(14):1591-5.
10. Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med. 2006; 166(9):955-64.
11. Gentry CA, Greenfield RA, Slater LN, Wack M, Huycke MM. Outcomes of an antimicrobial control program in a teaching hospital. Am J Health Syst Pharm. 2000;57(3):268-74.
12. Bond CA, Raehl CL. Clinical pharmacy services, pharmacy staffing, and hospital mortality rates. Pharmacotherapy. 2007;27(4):481-93.
13. MacLaren R, Bond CA. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events. Pharmacotherapy. 2009;29(7):761-8.